Login to Your Account



Ovid seeks 'transformation' and pipeline validation

By Marie Powers
News Editor

Wednesday, April 12, 2017

Rare disease player Ovid Therapeutics Inc. filed an S-1 with the SEC indicating its intention to raise up to $86.25 million in an IPO.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription